Cancer Research Coordinating Committee
Overview
► 849 awards since 1999
► $46M in program spending
► $85M in leveraged funding
► 4 Nobel Laureates received CRCC funding
The CRCC is a systemwide, UC faculty-directed cancer research program that provides competitive intramural research awards for topics in any discipline that address any aspect of cancer. Funding for this opportunity is provided through donations and bequests to UC for cancer research. The CRCC provides one-year seed grants to New Assistant Professors (NAP) or established faculty (REG) on the 10 UC campuses.
Initiating Cancer Research Across Campuses and Disciplines
CRCC awards supports both new and established faculty to launch cancer research projects, whether to accelerate their careers or to pivot their research in new directions. As a true systemwide resource, CRCC seed funding has reached every campus, sponsoring work across a wide range of disciplines, from biomedical sciences to behavioral research. Committed to catalyzing the next wave of breakthroughs in cancer research, the UC faculty-led committee invests in promising ideas at their earliest stages. Many awardees have gone on to secure major funding, turning these initial grants into large-scale impact.
Research Areas, 2017-present
Diversity and Disparities in Cancer Research Traineeship Supplement
Overview
Since 2020, CRCC has expanded its commitment to equity in cancer research through a targeted supplement opportunity for funding nominees. This initiative allows eligible applicants to request up to $10,000 in supplemental support aimed at advancing the careers of trainees from underrepresented backgrounds or those conducting research that addresses cancer’s impact in underserved communities. The intent of this supplement is to foster a pipeline of cancer researchers whose careers will enhance workforce diversity and/or strengthen research in topics that address cancer disparities. Details about the supplement opportunity are shared with applicants at the time they receive their review outcomes.